List of works - Noemi Rotllan

ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression

scientific article published on 27 July 2016

ATP-binding cassette G5/G8 deficiency causes hypertriglyceridemia by affecting multiple metabolic pathways.

scientific article published on 10 August 2011

Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis.

scientific article published on 22 March 2018

Age-associated vascular inflammation promotes monocytosis during atherogenesis.

scientific article published on 02 May 2016

Akt-mediated foxo1 inhibition is required for liver regeneration.

scientific article published on 16 October 2015

Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells

scientific article published on 24 January 2014

Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis.

scientific article published on 29 March 2018

CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection

scientific article published on 22 June 2007

Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis

scientific article published on 27 December 2012

Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation

scientific article published on 03 June 2019

Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice

scientific article published on 02 May 2016

Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes.

scientific article published on 29 November 2016

Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.

scientific article published on 21 March 2013

Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism

scientific article published on 31 August 2007

Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.

scientific article published on 30 November 2010

Direct evidence in vivo of impaired macrophage-specific reverse cholesterol transport in ATP-binding cassette transporter A1-deficient mice

scientific article published on 27 December 2005

Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice

scientific article published on 13 October 2009

Endothelial glucocorticoid receptor suppresses atherogenesis--brief report

scientific article

Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site

scientific article

Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis

scientific article published in October 2017

Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis

scientific article

Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis

scientific article published on 14 November 2019

Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells.

scientific article

Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease

scientific article published on 30 January 2019

Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis

scientific article

Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.

scientific article

Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells.

scientific article

Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.

scientific article published on 28 May 2008

Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis.

scientific article published on 3 July 2017

Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse

scientific article published on 6 January 2011

MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice.

scientific article published on 10 July 2014

MicroRNA 33 regulates glucose metabolism.

scientific article published on 28 May 2013

MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.

scientific article

MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels

scientific article

MicroRNAs and atherosclerosis.

scientific article

MicroRNAs and lipid metabolism.

scientific article published on 22 March 2017

Noncoding RNAs and atherosclerosis

scientific article

Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo

scientific article published on 30 June 2005

Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate

scientific article

Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration.

scientific article

Specific Disruption of Abca1 Targeting Largely Mimics the Effects of miR-33 Knockout on Macrophage Cholesterol Efflux and Atherosclerotic Plaque Development

scientific article published on 01 March 2019

Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages

scientific article (publication date: 2011)

miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression

scientific article published on 17 November 2020

miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice

scientific article published on 29 October 2015

microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain

scientific article

microRNAs in lipoprotein metabolism and cardiometabolic disorders.

scientific article published on 18 January 2016

List of works by Noemi Rotllan

ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression

ATP-binding cassette G5/G8 deficiency causes hypertriglyceridemia by affecting multiple metabolic pathways.

Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis.

Age-associated vascular inflammation promotes monocytosis during atherogenesis.

Akt-mediated foxo1 inhibition is required for liver regeneration.

Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells

Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis.

CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection

Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis

Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation

Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice

Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes.

Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.

Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism

Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.

Direct evidence in vivo of impaired macrophage-specific reverse cholesterol transport in ATP-binding cassette transporter A1-deficient mice

Disodium ascorbyl phytostanol phosphate (FM-VP4), a modified phytostanol, is a highly active hypocholesterolaemic agent that affects the enterohepatic circulation of both cholesterol and bile acids in mice

Endothelial glucocorticoid receptor suppresses atherogenesis--brief report

Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site

Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis

Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis

Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis

Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells.

Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease

Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis

Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.

Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells.

Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.

Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis.

Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse

MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice.

MicroRNA 33 regulates glucose metabolism.

MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.

MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels

MicroRNAs and atherosclerosis.

MicroRNAs and lipid metabolism.

Noncoding RNAs and atherosclerosis

Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo

Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate

Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration.

Specific Disruption of Abca1 Targeting Largely Mimics the Effects of miR-33 Knockout on Macrophage Cholesterol Efflux and Atherosclerotic Plaque Development

Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages

miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression

miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice

microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain

microRNAs in lipoprotein metabolism and cardiometabolic disorders.